Company Filing History:
Years Active: 2017
Title: Innovations in Cancer Treatment by Mohammad Seyed Taghdisi Heidarian
Introduction
Mohammad Seyed Taghdisi Heidarian is a notable inventor based in Mashhad, Iran. He has made significant contributions to the field of cancer diagnosis and treatment through his innovative research. His work focuses on the development of aptamers, which are short, single-stranded nucleic acids that can bind to specific targets.
Latest Patents
Heidarian holds a patent for "Aptamers and use of the aptamers in the diagnosis and treatment of cancer." This invention relates to an aptamer comprising a nucleotide sequence SEQ ID NO: 1, a composition comprising an aptamer, and the use of the aptamer in the diagnosis and treatment of cancer, particularly solid tumors. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Heidarian is affiliated with Rheinische Friedrich-Wilhelms-Universität Bonn, where he continues to engage in groundbreaking research. His academic background and professional experience have positioned him as a key figure in the field of cancer research.
Collaborations
He has collaborated with esteemed colleagues such as Günter Mayer and Ursula Maria Katia Schöler. These partnerships have further enriched his research and contributed to the advancement of cancer treatment methodologies.
Conclusion
Mohammad Seyed Taghdisi Heidarian's work in developing aptamers for cancer diagnosis and treatment represents a significant step forward in medical innovation. His contributions are vital in the ongoing fight against cancer, and his research continues to inspire future advancements in the field.